Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess the efficacy and safety of Shengdi Dahuang Decoction in the treatment of acute hemorrhagic stroke by the randomized, controlled, double-blind, multi-center trial design project.


Clinical Trial Description

The main purpose of the study is to observe the clinical efficacy and safety of Shengdi Dahuang Decoction in the treatment of acute hemorrhagic stroke. This project is funded by Science and Technology Commission of Shanghai Municipality and will be carried out in 5 hospitals. Investigators will recruit 464 participants who meet the inclusion criteria and agree to participate in the research. Participants will be randomly assigned into experimental or placebo group. Granules of Shengdi Decoction is the therapeutic drug used in the experimental group. Each pack of the test drug contains 15 grams of rehmannia and 5 grams of rhubarb. While for the placebo group, each pack contains 2% rehmannia and rhubarb. Participants will receive a follow-up observation in the following 90 days. Modified Rankin Scale score (mRS), the mortality rate on day 7 and day 90 after treatment, National Institute of Health Stroke Scale (NIHSS), expansion rate of hematoma, the degree of edema and the expressions of inflammatory indicators will be detected to evaluate the clinical efficacy of Shengdi Dahuang Decoction. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04200781
Study type Interventional
Source ShuGuang Hospital
Contact Xiaoyu Yu
Phone 86-021-20256378
Email doctorxiaoyu@sina.com
Status Recruiting
Phase Phase 4
Start date September 1, 2019
Completion date June 30, 2022

See also
  Status Clinical Trial Phase
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Not yet recruiting NCT06026696 - Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
Completed NCT01573117 - A Randomized Trial Comparing 2 Methods for Rapid Induction of Cooling in Stroke Patients, Cold Infusions vs. RhinoChill (iCOOL 1) Phase 2
Completed NCT03292211 - The Effect of Early Mobilization in Mild to Moderate Hemorrhagic Stroke N/A
Not yet recruiting NCT06069973 - Using Machine Learning and Biomarkers for Early Detection of Delayed Cerebral Ischemia
Not yet recruiting NCT05816213 - Point-of-care Low-field MRI in Acute Stroke
Not yet recruiting NCT05502874 - Multicenter Registry for Assessment of Markers of Early Neurological Deterioration in Primary Intracerebral Hemorrhage
Recruiting NCT04534556 - Wireless Nerve Stimulation Device To Enhance Recovery After Stroke N/A
Recruiting NCT05440682 - Connectivity in Cranioplasty N/A
Completed NCT05121415 - Investigation of Genetic Disease Marker Associated With Spontaneous Haemorrhagic Stroke Complicating Severe Pre-eclampsia in Pregnancy
Terminated NCT02626377 - Multicenter Prospective Cohort of Informal Caregivers in Burgundy and Franche-Comté N/A
Completed NCT01942031 - Improved Prevention of Stroke in Primary Care in Stockholm, Sweden (Förbättrad Prevention av Stroke) N/A
Completed NCT01845350 - Safety of Autologous M2 Macrophage in Treatment of Non-Acute Stroke Patients Phase 1
Recruiting NCT05865795 - Mapping the Natural History of Parenychymal and Cerebral Perfusion Changes in Acute Ischemic and Hemorrhagic Strokes
Completed NCT04612218 - Biomarkers for Initiating Onsite and Faster Ambulance Stroke Therapies
Recruiting NCT06134921 - Effects of Transcranial Electrical Stimulation in Stroke Individuals N/A
Recruiting NCT06190314 - SERUM VITAMIN B12 LEVELS IN PATIENTS WITH HEMORRHAGIC VS ISCHEMIC CEREBROVASCULAR EVENT.
Recruiting NCT05735405 - Aerobic Exercise and Cognitive Training in Patients With Stroke N/A
Recruiting NCT06107725 - Maimonides Minocycline in Stroke Study Phase 2/Phase 3
Completed NCT05916885 - Effects of Short-intensity Modified Constraint-induced Movement Therapy on Hand Function in Stroke Patients. N/A